Shiro Miyata

Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma

Shinji Kawabata, Shin-Ichi Miyatake, Toshihiko Kuroiwa et al. · Journal of Radiation Research · 2009 · 144 citations · Full text

Neuro-oncology, Radiation Therapy, Protocol 2 +15

Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) Is Required for Branching Morphogenesis in the Chorioallantoic Placenta

Hiroyuki Tanaka, Koki Nagaike, Naoki Takeda et al. · Molecular and Cellular Biology · 2005 · 100 citations · Full text

Human Placenta, Developmental Biology, Tissue Development +15

Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients

Shinji Kawabata, Shin-Ichi Miyatake, Naosuke Nonoguchi et al. · Applied Radiation and Isotopes · 2009 · 79 citations

Neuro-oncology, Survival Benefit, Radiation Therapy +11

Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice

Hiroshi Itoh, Seiji Naganuma, Naoki Takeda et al. · Gastroenterology · 2004 · 73 citations · Full text

Inflammation, Regenerative Medicine, Liver Physiology +11

Phase II clinical study of boron neutron capture therapy combined with X-ray radiotherapy/temozolomide in patients with newly diagnosed glioblastoma multiforme—Study design and current status report

Shinji Kawabata, Shin‐Ichi Miyatake, Ryo Hiramatsu et al. · Applied Radiation and Isotopes · 2011 · 59 citations

Neuro-oncology, Radiation Medicine, X-ray Radiotherapy/temozolomide +11